Biochip
Description
The broken lines depict portions of the biochip that form no part of the claimed design.
Claims
We claim the ornamental design for a biochip, as shown and described.
Referenced Cited
U.S. Patent Documents
Foreign Patent Documents
Other references
D146697 | April 1947 | Bates |
D224671 | August 1972 | Eddy |
D237317 | October 1975 | Nowakowski |
D242654 | December 7, 1976 | Rawls |
D280290 | August 27, 1985 | Bakus |
D440118 | April 10, 2001 | Claffy |
D605896 | December 15, 2009 | Zalewski |
D838380 | January 15, 2019 | Self |
D908436 | January 26, 2021 | Lu |
D918417 | May 4, 2021 | O'Mahony |
D921220 | June 1, 2021 | Motomura |
20050112545 | May 26, 2005 | Chapman |
20100068101 | March 18, 2010 | Sim |
307005407 | December 2021 | CN |
- Hydrogel based protein biochip for parallel detection of biomarkers for diagnosis of a Systemic Inflammatory Response Syndrome (SIRS) in human serum. Online, published date unknown. Retrieved on Jan. 24, 2023 from URL: https://journals.plos.org/plosone/article/figure?id=10.1371/journal.pone.0225525.g003.
Patent History
Patent number: D998171
Type: Grant
Filed: Sep 3, 2021
Date of Patent: Sep 5, 2023
Assignee: Shen Zhen Biorocks Biotechnology Company Limited (ShenZhen)
Inventors: Ho Nam Chan (Shenzhen), Yiwei Shu (Shenzhen)
Primary Examiner: Omeed Agilee
Application Number: 29/806,586
Type: Grant
Filed: Sep 3, 2021
Date of Patent: Sep 5, 2023
Assignee: Shen Zhen Biorocks Biotechnology Company Limited (ShenZhen)
Inventors: Ho Nam Chan (Shenzhen), Yiwei Shu (Shenzhen)
Primary Examiner: Omeed Agilee
Application Number: 29/806,586
Classifications
Current U.S. Class:
Plural Divisions (D24/226)